HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of adipokines and indices of metabolic syndrome as predictors of severe obesity-related hepatic steatosis.

Abstract
The aim of this study was to investigate adiponectin, leptin, and metabolic syndrome as predictors of the severity of obesity-related steatosis. By ultrasonography steatosis-positive (cases) subjects (n = 141) were compared with controls (n = 111). Demographic and anthropometric data and serum concentrations of adiponectin, leptin, and insulin were measured. The impact of several criteria of metabolic syndrome, serum adiponectin concentrations, and serum leptin concentrations were tested using a multivariate logistic regression analysis. The frequency of metabolic syndrome was higher in cases (44.0% versus 9.2%; P < .0001). Cases were older and had higher insulin resistance, waist circumference, and lower concentrations of adiponectin (all P < .001). The upper adiponectin quartile was associated with a lesser grade of steatosis. Metabolic syndrome and adiponectin concentrations were independently associated with the probability of steatosis. In conclusion, adipokines and metabolic syndrome are useful indices for the prediction of the severity of obesity-related steatosis.
AuthorsNahum Méndez-Sánchez, Norberto C Chávez-Tapia, Roberto Medina-Santillán, Antonio R Villa, Karla Sánchez-Lara, Guadalupe Ponciano-Rodríguez, Martha H Ramos, Misael Uribe
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 51 Issue 10 Pg. 1716-22 (Oct 2006) ISSN: 0163-2116 [Print] United States
PMID17203555 (Publication Type: Journal Article)
Chemical References
  • Adiponectin
  • Leptin
Topics
  • Adiponectin (blood)
  • Adult
  • Case-Control Studies
  • Cross-Sectional Studies
  • Fatty Liver (blood, diagnostic imaging, etiology)
  • Female
  • Humans
  • Leptin (blood)
  • Logistic Models
  • Male
  • Metabolic Syndrome (blood, complications, diagnostic imaging)
  • Middle Aged
  • Obesity (blood, complications, diagnostic imaging)
  • Severity of Illness Index
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: